Testing and Reporting
Interim Guidance on Testing, Specimen Collection, and Processing for Patients with Suspected Infection with Novel Influenza A Viruses with the Potential to Cause Severe Disease in Humans
Diagnostics for Detecting H7N9 Using rRT-PCR

Infection Control
Interim Guidance for Infection Control Within Healthcare Settings for Confirmed Cases, Probable Cases, and Cases Under Investigation for Infection with Novel Influenza A Viruses Associated with Severe Disease

Antiviral Treatment and ChemoprophylaxisEvaluating and Managing Patients

Evaluating and Managing Patients Exposed to Birds Infected with Avian Influenza A Viruses of Public Health Concern

Treatment

Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease

Chemoprophylaxis of Persons with Bird Exposure

Interim Guidance on Influenza Antiviral Chemoprophylaxis of Persons Exposed to Birds with Avian Influenza A Viruses Associated with Severe Human Disease or with the Potential to Cause Severe Human Disease

Chemoprophylaxis of Close Contacts

Interim Guidance on Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses Associated with Severe Human Disease and on the Use of Antiviral Medications for Chemoprophylaxis


Case Definitions
Case Definitions for Investigations of Human Infection with Avian Influenza A Viruses in the United States

HAN: CDC Health Advisories
Highly Pathogenic Avian Influenza A(H5N1) Virus: Recommendations for Human Health Investigations and Response April 29, 2022
Bird Infections with Highly-Pathogenic Avian Influenza A (H5N2), (H5N8), and (H5N1) Viruses: Recommendations for Human Health Investigations and Response (Archived) June 2, 2015

Vaccine Development
Candidate vaccine viruses and potency testing reagents for influenza A(H5N1), WHO pdf icon[175 KB, 2 pages]external icon
Making a Candidate Vaccine Virus (CVV) for a Highly Pathogenic Avian Influenza (Bird Flu) Virus
Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses, WHO pdf icon[198 KB, 3 pages]external icon
Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza vaccines against avian influenza A(H7N9) virus pdf icon[604 KB, 13 pages]external icon


